Dow Jones

40 211,72

0,53%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
22/05/2018	23h15	GlobeNewswire Inc.	Insmed Announces Presentations at the American Thoracic Society 2018 International Conference	NASDAQ:INSM	Insmed Inc
17/05/2018	22h19	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:INSM	Insmed Inc
17/05/2018	22h18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
17/05/2018	22h12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INSM	Insmed Inc
17/05/2018	22h05	GlobeNewswire Inc.	Insmed Appoints Leo Lee to its Board of Directors	NASDAQ:INSM	Insmed Inc
16/05/2018	14h00	GlobeNewswire Inc.	Insmed Announces FDA Acceptance for Filing of New Drug Application for ALIS in NTM Lung Disease Caused by MAC	NASDAQ:INSM	Insmed Inc
02/05/2018	15h21	GlobeNewswire Inc.	Insmed to Present at the Deutsche Bank 43rd Annual Health Care Conference	NASDAQ:INSM	Insmed Inc
02/05/2018	14h01	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:INSM	Insmed Inc
02/05/2018	13h30	GlobeNewswire Inc.	Insmed Reports First Quarter 2018 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
25/04/2018	14h00	GlobeNewswire Inc.	Insmed to Host First Quarter 2018 Financial Results Conference Call on Wednesday, May 2, 2018	NASDAQ:INSM	Insmed Inc
05/04/2018	18h59	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:INSM	Insmed Inc
05/04/2018	18h57	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:INSM	Insmed Inc
29/03/2018	14h00	GlobeNewswire Inc.	Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC	NASDAQ:INSM	Insmed Inc
27/03/2018	22h30	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:INSM	Insmed Inc
07/03/2018	14h00	GlobeNewswire Inc.	Insmed to Present at the Cowen and Company 38th Annual Health Care Conference	NASDAQ:INSM	Insmed Inc
23/02/2018	14h03	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:INSM	Insmed Inc
23/02/2018	13h30	GlobeNewswire Inc.	Insmed Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
21/02/2018	23h26	GlobeNewswire Inc.	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:INSM	Insmed Inc
20/02/2018	14h00	GlobeNewswire Inc.	Insmed Extends ALIS Intellectual Property Protection to 2035 with Issuance of Ninth U.S. Patent	NASDAQ:INSM	Insmed Inc
15/02/2018	14h00	GlobeNewswire Inc.	Insmed to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call on Friday, February 23, 2018	NASDAQ:INSM	Insmed Inc
15/02/2018	00h49	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:INSM	Insmed Inc
12/02/2018	23h19	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:INSM	Insmed Inc
07/02/2018	22h30	GlobeNewswire Inc.	Insmed to Present at the Leerink Partners 7th Annual Global Healthcare Conference	NASDAQ:INSM	Insmed Inc
26/01/2018	18h00	GlobeNewswire Inc.	Insmed Announces Closing of Public Offering	NASDAQ:INSM	Insmed Inc
24/01/2018	22h21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:INSM	Insmed Inc
24/01/2018	12h06	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NASDAQ:INSM	Insmed Inc
24/01/2018	04h49	GlobeNewswire Inc.	Insmed Announces Pricing of Public Offering of Convertible Senior Notes	NASDAQ:INSM	Insmed Inc
22/01/2018	22h05	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:INSM	Insmed Inc
22/01/2018	22h01	GlobeNewswire Inc.	Insmed Announces Proposed Public Offering of Convertible Senior Notes	NASDAQ:INSM	Insmed Inc
03/01/2018	22h10	GlobeNewswire Inc.	Insmed Announces Additional Data from ALIS (Amikacin Liposome Inhalation Suspension) Phase 3 Clinical Program for Adult Patie...	NASDAQ:INSM	Insmed Inc